title: Intranasal interferon-alpha 2 prophylaxis of natural respiratory virus infection.
authors.forename: R M
authors.initials: RM
authors.lastname: Douglas
authors.forename: J K
authors.initials: JK
authors.lastname: Albrecht
authors.forename: H B
authors.initials: HB
authors.lastname: Miles
authors.forename: B W
authors.initials: BW
authors.lastname: Moore
authors.forename: R
authors.initials: R
authors.lastname: Read
authors.forename: D A
authors.initials: DA
authors.lastname: Worswick
authors.forename: A J
authors.initials: AJ
authors.lastname: Woodward
mesh_terms: D000260:Adenoviruses, Human / Q000302:isolation & purification; D000281:Administration, Intranasal; D000293:Adolescent; D000328:Adult; D000368:Aged; D003139:Common Cold / Q000517:prevention & control / Q000635:transmission; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009666:Nose / Q000382:microbiology; D011897:Random Allocation; D012141:Respiratory Tract Infections / Q000517:prevention & control* / Q000635:transmission; D018108:Respirovirus / Q000302:isolation & purification; D012229:Rhinovirus / Q000302:isolation & purification; D014777:Virus Diseases / Q000517:prevention & control*
chemical_list: D007370:Interferon Type I